346 related articles for article (PubMed ID: 8262843)
21. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
22. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Wilson GD; Dische S; Saunders MI
Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study.
Jaulerry C; Dubray B; Brunin F; Rodriguez J; Point D; Blaszka B; Asselain B; Mosseri V; Brugere J; Cosset JM
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):271-9. PubMed ID: 7673014
[TBL] [Abstract][Full Text] [Related]
25. Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy.
Smeele LE; Leemans CR; Langendijk JA; Tiwari R; Slotman BJ; van Der Waal I; Snow GB
Head Neck; 2000 Sep; 22(6):559-63. PubMed ID: 10941156
[TBL] [Abstract][Full Text] [Related]
26. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
27. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
[TBL] [Abstract][Full Text] [Related]
28. Cell proliferation activity and kinetic profile in the prognosis and therapeutic management of carcinoma of the pharynx and larynx.
Myers EN; Sampedro A; Alvarez C; Martínez Ja; Suárez C; Alonso-Guervós M; de los Toyos JR
Otolaryngol Head Neck Surg; 1999 Oct; 121(4):476-81. PubMed ID: 10504608
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
30. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
31. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.
Nordsmark M; Overgaard J
Acta Oncol; 2004; 43(4):396-403. PubMed ID: 15303502
[TBL] [Abstract][Full Text] [Related]
32. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report.
Arias F; Domínguez MA; Illarramendi JJ; Martínez E; Tejedor M; Domínguez S; Dueñas M; Villafranca E; Elcarte F; Miquéliz S
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):675-82. PubMed ID: 7558958
[TBL] [Abstract][Full Text] [Related]
33. [Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
Mariya Y; Aoki M; Tarusawa N; Takekawa S; Kaimori M; Abe Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):976-8. PubMed ID: 8371947
[TBL] [Abstract][Full Text] [Related]
34. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
Erba E; Giordano M; Danova M; Mazzini G; Ubezio P; Torri V; Mangioni C; Landoni F; Bolis P; Tenti P
Ann Oncol; 1994 Sep; 5(7):627-34. PubMed ID: 7993839
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
Wenz F; Lohr F; Flentje M; Rudat V; Dietz A; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):771-6. PubMed ID: 9128950
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
37. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
[TBL] [Abstract][Full Text] [Related]
38. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications.
Nylander K; Anneroth G; Gustafsson H; Roos G; Stenling R; Zackrisson B
Acta Oncol; 1994; 33(1):23-8. PubMed ID: 8142119
[TBL] [Abstract][Full Text] [Related]
39. Interrelationships of DNA-ploidy and cell proliferation markers with T-stage and N-stage in primary laryngeal tumors.
Struikmans H; Rutgers DH; Hordijk GJ; Slootweg PJ; van der Tweel I; Battermann JJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):303-8. PubMed ID: 9457813
[TBL] [Abstract][Full Text] [Related]
40. Proliferative capacity in head and neck cancer.
Struikmans H; Kal HB; Hordijk GJ; van der Tweel I
Head Neck; 2001 Jun; 23(6):484-91. PubMed ID: 11360311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
